We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.
To save content items to your account,
please confirm that you agree to abide by our usage policies.
If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account.
Find out more about saving content to .
To save content items to your Kindle, first ensure no-reply@cambridge.org
is added to your Approved Personal Document E-mail List under your Personal Document Settings
on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part
of your Kindle email address below.
Find out more about saving to your Kindle.
Note you can select to save to either the @free.kindle.com or @kindle.com variations.
‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi.
‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.
We simulate the dynamics, including laser cooling, of three-dimensional (3-D) ion crystals confined in a Penning trap using a newly developed molecular dynamics-like code. The numerical integration of the ions’ equations of motion is accelerated using the fast multipole method to calculate the Coulomb interaction between ions, which allows us to efficiently study large ion crystals with thousands of ions. In particular, we show that the simulation time scales linearly with ion number, rather than with the square of the ion number. By treating the ions’ absorption of photons as a Poisson process, we simulate individual photon scattering events to study laser cooling of 3-D ellipsoidal ion crystals. Initial simulations suggest that these crystals can be efficiently cooled to ultracold temperatures, aided by the mixing of the easily cooled axial motional modes with the low frequency planar modes. In our simulations of a spherical crystal of 1000 ions, the planar kinetic energy is cooled to several millikelvin in a few milliseconds while the axial kinetic energy and total potential energy are cooled even further. This suggests that 3-D ion crystals could be well suited as platforms for future quantum science experiments.
In November 2023, the Department of Health and Social Care published guidance, entitled ‘Baroness Hollins’ Final Report: My Heart Breaks – Solitary Confinement in Hospital Has no Therapeutic Benefit for People with a Learning Disability and Autistic People’. The report's commendable analysis of the problems and identification of the areas where practice should be improved is unfortunately not matched by many of its recommendations, which appear to be contrary to evidence-based approaches. The concerns are wide-ranging, from the use of the term ‘solitary confinement’ for current long-term segregation (LTS) and seclusion, to presumption that all LTS and seclusion is bad, to holding clinicians (mainly psychiatrists) responsible for events beyond their locus of control. Importantly, there is a no guidance on how to practically deliver the recommendations in an evidence-based manner. This Feature critically appraises the report, to provide a comprehensive summary outlining potential positive impacts, identifying specific concerns and reflecting on best practice going forward.
Among participants with Alzheimer's disease (AD) we estimated the minimal clinically important difference (MCID) in apathy symptom severity on three scales.
Design:
Retrospective anchor- and distribution-based analyses of change in apathy symptom scores.
Setting:
Apathy in Dementia Methylphenidate Trial (ADMET) and ADMET 2 randomized controlled trials conducted at three and ten clinics specialized in dementia care in United States and Canada, respectively.
Participants:
Two hundred and sixty participants (60 ADMET, 200 ADMET 2) with clinically significant apathy in Alzheimer’s disease.
Measurements:
The Clinical Global Impression of Change in Apathy scale was used as the anchor measure and the MCID on the Neuropsychiatric Inventory – Apathy (NPI-A), Dementia Apathy Interview and Rating (DAIR), and Apathy Evaluation Scale-Informant (AES-I) were estimated with linear mixed models across all study visits. The estimated thresholds were evaluated with performance metrics.
Results:
Among the MCID was a decrease of four points (95% CI: −4.0 to −4.8) on the NPI-A, 0.56 points (95% CI: −0.47 to −0.65) on the DAIR, and three points on the AES-I (95% CI: −0.9 to −5.4). Distribution-based analyses were largely consistent with the anchor-based analyses. The MCID across the three measures showed ∼60% accuracy. Sensitivity analyses found that MMSE scores and apathy severity at baseline influenced the estimated MCID.
Conclusions:
MCIDs for apathy on three scales will help evaluate treatment efficacy at the individual level. However, the modest correspondence between MCID and clinical impression of change suggests the need to consider other scales.
To assess cost-effectiveness of late time-window endovascular treatment (EVT) in a clinical trial setting and a “real-world” setting.
Methods:
Data are from the randomized ESCAPE trial and a prospective cohort study (ESCAPE-LATE). Anterior circulation large vessel occlusion patients presenting > 6 hours from last-known-well were included, whereby collateral status was an inclusion criterion for ESCAPE but not ESCAPE-LATE. A Markov state transition model was built to estimate lifetime costs and quality-adjusted life-years (QALYs) for EVT in addition to best medical care vs. best medical care only in a clinical trial setting (comparing ESCAPE-EVT to ESCAPE control arm patients) and a “real-world” setting (comparing ESCAPE-LATE to ESCAPE control arm patients). We performed an unadjusted analysis, using 90-day modified Rankin Scale(mRS) scores as model input and analysis adjusted for baseline factors. Acceptability of EVT was calculated using upper/lower willingness-to-pay thresholds of 100,000 USD/50,000 USD/QALY.
Results:
Two-hundred and forty-nine patients were included (ESCAPE-LATE:n = 200, ESCAPE EVT-arm:n = 29, ESCAPE control-arm:n = 20). Late EVT in addition to best medical care was cost effective in the unadjusted analysis both in the clinical trial and real-world setting, with acceptability 96.6%–99.0%. After adjusting for differences in baseline variables between the groups, late EVT was marginally cost effective in the clinical trial setting (acceptability:49.9%–61.6%), but not the “real-world” setting (acceptability:32.9%–42.6%).
Conclusion:
EVT for LVO-patients presenting beyond 6 hours was cost effective in the clinical trial setting and “real-world” setting, although this was largely related to baseline patient differences favoring the “real-world” EVT group. After adjusting for these, EVT benefit was reduced in the trial setting, and absent in the real-world setting.
Semantic segmentation is a critical part of observation-driven research in glaciology. Using remote sensing to quantify how features change (e.g. glacier termini, supraglacial lakes, icebergs, crevasses) is particularly important in polar regions, where glaciological features may be spatially small but reflect important shifts in boundary conditions. In this study, we assess the utility of the Segment Anything Model (SAM), released by Meta AI Research, for cryosphere research. SAM is a foundational AI model that generates segmentation masks without additional training data. This is highly beneficial in polar science because pre-existing training data rarely exist. Widely-used conventional deep learning models such as UNet require tens of thousands of training labels to perform effectively. We show that the Segment Anything Model performs well for different features (icebergs, glacier termini, supra-glacial lakes, crevasses), in different environmental settings (open water, mélange, and sea ice), with different sensors (Sentinel-1, Sentinel-2, Planet, timelapse photographs) and different spatial resolutions. Due to the performance, versatility, and cross-platform adaptability of SAM, we conclude that it is a powerful and robust model for cryosphere research.
Background: Orbital infarction syndrome (OIS) is a rare entity defined as acute ischemia of intraorbital structures. Three case reports of OIS post-endovascular thrombectomy (EVT) have recently been published, two demonstrating absent choroid blush (CB) on digital subtraction angiogram (DSA). Our goals are to determine the true incidence of OIS post-EVT and to identify imaging findings (e.g. CB) that may alert neurologists to potential cases. Methods: A retrospective cohort study including all EVT patients from Health Sciences Center (HSC), Winnipeg in 2019-20 was performed. Patient charts were reviewed to determine the incidence of OIS. Pre- and post-EVT DSA images were reviewed, and the sensitivity and specificity of absent CB for OIS was calculated. Results: Out of 248 patients, 13 were excluded for incomplete charts, and 4 cases (1.7%) of OIS were discovered. During sensitivity/specificity analysis of absent CB for OIS, 51 patients were excluded for inadequate imaging. There were 4 true positives, 0 false-negatives, 113 true-negatives, and 67 false-positives; resulting in a sensitivity of 100% and worst-case scenario specificity of 63% (assuming all 51 indeterminate cases were false positives). Conclusions: OIS is rare post-EVT with an incidence of 1.7%. Absent CB is very sensitive for diagnosing OIS with lower specificity.
Background: Women are reported to have worse outcomes than men following ischemic stroke despite similar treatment effects for thrombolysis and endovascular treatment. Methods: We performed a post-hoc analysis of patients with acute ischemic stroke and intracranial occlusion enrolled in INTERRSeCT, an international prospective cohort study. We compared workflow times, reperfusion therapy choices, and 90-day modified Rankin scale (mRS) scores. Results: We included 575 patients, mean age 70.2 years (SD: 13.1) and 48.5% female. There were no significant sex differences in onset-to-CT (males: 115 minutes [IQR: 72-171], females: 114 minutes [IQR: 75-196] ) or CT-to-thrombolysis time (males: 24 minutes [IQR: 17-32], females: 23 minutes [IQR: 18-36]). However, female participants had a 12-minute faster CT-to-groin-puncture time, p=0.001. Reperfusion therapies did not significantly differ by sex. Reperfusion therapies included thrombolysis alone (males: 46%, females: 49%), EVT alone (males: 34%, females: 34%), thrombolysis plus EVT (males: 8%, females 9%) and conservative management (males: 12%, females: 8%). Median 90-day mRS was 2 (IQR: 1-4) in both males and females, p=0.1. Conclusions: In the INTERRSeCT cohort, rates of reperfusion therapy, workflow times and 90-day outcomes were similar between sexes, suggesting that women are not subject to any poorer performance in key quality indicators for reperfusion treatment for acute stroke.
Background: Radiologic imaging has become integral in not only the detection and diagnosis of subdural hematoma, but also in guiding potential treatment options. Particularly, in the arena of chronic subdural hematoma, which has conventionally been managed via surgical drainage, although is shifting toward procedural intervention with embolization of the middle meningeal artery. This paper aims to review the imaging manifestations of subdural hematoma as a function of chronicity, standardized methods of measurement, and identifying the middle meningeal artery and its clinically significant variant anatomy as it pertains to embolization planning. Methods: A literature search using key terms and titles was conducted for articles containing imaging characteristics of subdural hematoma, approaches to measurement, and middle meningeal artery anatomy as the primary focus. Results: The expected evolution of subdural hematoma over time encompasses a broad array of imaging characteristics. Attempts at standardizing hematoma measurements include width, volume, and midline shift. Given the implication of the middle meningeal artery in potential therapeutic embolization, familiarity with its anatomy is vital not only for mapping access, but also for delineating possible dangerous collaterals. Conclusions: Equipped with a more comprehensive approach to characterizing subdural hematoma, the radiologist will be able to curate findings of greater utility to the clinician.
Background: The burden and outcome of stroke in indigenous populations is less well understood. This review evaluates ischemic stroke outcomes in indigenous populations as compared to the general population in the context of recent advances in ischemic stroke therapy. Methods: The OVID Medline and EMBASE databases were searched for this review. Clinical outcome was measured using standardized outcome scale (eg. mRS) at 90 days following stroke intervention in indigenous as compared to non-indigenous adult populations. Results: 897 studies were identified, with 4 studies included in the final analysis. A total of (n=68895) patients were included who underwent thrombolysis. Study populations from Australia, New Zealand, United States and Canada comprised of (n=2012) indigenous patients. Mortality was significantly higher in indigenous populations as compared to non-indigenous (Odds Ratio-1.28, 95% CI-1.12; 1.46). The odds ratios of atrial fibrillation (1.26, 95% CI-1.12;– 1.41), diabetes (1.43, 95% CI- 1.27; 1.62), hypertension (1.33, 95% CI- 1.17; 1.51) and IHD (0.71, 95% CI- 0.62; 0.81) in indigenous patients was significantly higher than in non-indigenous patients. Conclusions: Indigenous populations undergoing stroke therapy are at a significantly increased risk of mortality as compared to non-indigenous populations. Comorbidities including diabetes, atrial fibrillation and hypertension are more prevalent in indigenous populations.
Background: Thrombolysis (tPA) and endovascular thrombectomy (EVT) are interventions for acute ischemic stroke (AIS) that can be accompanied by intracerebral hemorrhage (ICH), which can alter the patient’s management, or contrast extravasation (CE), which is relatively benign. Previous retrospective studies have shown that dual-energy CT (DECT) is significantly more accurate for differentiating ICH from CE compared to conventional, single-energy CT (SECT). We are performing a prospective study to investigate this question. Methods: Our primary outcome is the sensitivity and specificity of DECT in differentiating ICH from CE. In AIS patients who receive intervention, we will be performing a DECT scan at the same time as the standard-of-care SECT scan at 24 hours post-intervention. In patients who have a hyperdensity on CT, a repeat scan will be done at 72-hours, which will be used as the gold-standard to determine if the hyperdensity was ICH or CE. Results: We expect that DECT will be significantly more sensitive and specific for differentiating ICH from CE compared to SECT. Conclusions: This study will determine if DECT is superior to SECT in differentiating ICH from CE, validate the use of DECT in AIS patients who receive intervention, and potentially change the imaging paradigm for acute stroke in the future.
Background: Sex differences in treatment response to intravenous thrombolysis (IVT) are poorly characterized. We compared sex-disaggregated outcomes in patients receiving IVT for acute ischemic stroke in the Alteplase compared to Tenecteplase (AcT) trial, a Canadian multicentre, randomised trial. Methods: In this post-hoc analysis, the primary outcome was excellent functional outcome (modified Rankin Score [mRS] 0-1) at 90 days. Secondary and safety outcomes included return to baseline function, successful reperfusion (eTICI≥2b), death and symptomatic intracerebral hemorrhage. Results: Of 1577 patients, there were 755 women and 822 men (median age 77 [68-86]; 70 [59-79]). There were no differences in rates of mRS 0-1 (aRR 0.95 [0.86-1.06]), return to baseline function (aRR 0.94 [0.84-1.06]), reperfusion (aRR 0.98 [0.80-1.19]) and death (aRR 0.91 [0.79-1.18]). There was no effect modification by treatment type on the association between sex and outcomes. The probability of excellent functional outcome decreased with increasing onset-to-needle time. This relation did not vary by sex (pinteraction 0.42). Conclusions: The AcT trial demonstrated comparable functional, safety and angiographic outcomes by sex. This effect did not differ between alteplase and tenecteplase. The pragmatic enrolment and broad national participation in AcT provide reassurance that there do not appear to be sex differences in outcomes amongst Canadians receiving IVT.
Antiseizure medications (ASMs) are the second most widely prescribed psychotropic for people with intellectual disabilities in England. Multiple psychotropic prescribing is prevalent in almost half of people with intellectual disabilities on ASMs. This analysis identifies limited evidence of ASM benefit in challenging behaviour management and suggests improvements needed to inform clinical practice.
Background: The purpose of this systematic review was to synthesize evidence based on existing studies on the ability of initial imaging to predict mortality in severe traumatic brain injuries (TBIs) in pediatric patients. Methods: An experienced librarian searched for all existing studies based on the inclusion and exclusion criteria. The studies were screened by two blinded reviewers. The data was extracted to calculate the sensitivity (SN), specificity (SP), positive predictive value (PPV), negative predicted value (NPV), area under the curve (AUC), and receiver operating characteristic (ROC) for extradural hematoma (EDH), subdural hematoma (SDH), traumatic subarachnoid hemorrhage (tSAH), skull fractures, and edema. Results: Of the 3277 studies included in the search, data could only be extracted from 22 studies. There were a total of 2219 patients, 747 females, and 1461 males. 564 patients died and 1651 survived. 293 patients had SDH, 76 had EDH, 347 had tSAH, 244 had skull fractures, and 416 had edema. Seven of the studies had sufficient data to calculate the AUC, ROC, and generate a forest plot for the imaging findings. Conclusions: Out of the different CT scan findings, brain edema had the highest SN, PPV, NPV, and AUC. EDH had the highest SP to predict in hospital mortality.
Background: Chronic subdural hematoma (CSDH) is of the most encountered neurosurgical cases, predominantly in older individuals. Surgical drainage remains the mainstay, yet is challenged by variable recurrence rates. Less invasive methods of embolization of the middle meningeal artery (EMMA) could reduce the recurrence rates. Before adopting a newer treatment (EMMA), it is prudent to establish the outcomes from surgical drainage. The purpose of this study is to assess the clinical outcome and recurrence risk in surgically treated CSDH patients. Methods: A retrospective search of our surgical database was done to identify CSDH patients undergoing surgical drainage in 2019-2020. Demographic and clinical details were collected through chart review and a qualitative statistical analysis was performed. Results: A total of 136 patients (mean age-68 years; range-21-100 years; Male-105) with CSDH underwent surgical drainage with repeat surgery in 11.8%(n=16). Periprocedural mortality and morbidity were 8.8%(n=12) and 20.6%(n=28), respectively. No radiological follow-up was seen in 30(22%) of patients. Of those with follow-up, recurrence was seen in 21.7%(n=23). Mean hospital stay was 9.64 days. Conclusions: Our retrospective study showed periprocedural morbidity (20.6%) and mortality (8.8%) with a 21.7% risk of recurrence. This is likely due to older patients but is in keeping with what is reported in the literature.
Background: Embolization of middle meningeal artery (EMMA) is an emerging treatment for CSDH and a method to decrease CSDH recurrence. We report a single Canadian center experience of EMMA for the management of CSDH. Methods: Consecutive EMMA patients during the period July 2020 to September 2021 were retrospectively included in this series. EMMA procedures were performed using polyvinyl alcohol particles or liquid embolic agent. All patients were followed clinically and radiographically as per standard of care. Results: A total of 20 patients CSDH (mean 65.6 years; range 14-85 yrs; male 16) underwent 20 EMMA procedures. CSDH occured on the left in 13 patients, right in 4 patients and bilateral in 3 patients. No patients had periprocedural complications. There was no recurrence of CSDH on the EMMA treated side. The mean SDH size decreased from 18.4 +/- 6.34 mm at the time of presentation to 5.31 +/ 3.84 mm at last follow up. The proportion of patients with an mRS of 2 or less increased from 65% to 76%. Conclusions: EMMA was found to be effective and safe in the management of CSDH with no evidence of recurrence on the treated side. Left sided hematomas appear to be more common that right sided hematomas.
Background: The coronavirus disease 2019 (COVID-19) pandemic has led the implementation of institutional infection control protocols. This study will determine the effects of these protocols on outcomes of acute ischemic stroke (AIS) patients treated with endovascular therapy (EVT). Methods: Uninterrupted time series analysis of the impact of COVID-19 safety protocols on AIS patients undergoing EVT. We analyze data from prospectively collected quality improvement databases at 6 centers from March 11, 2019 to March 10, 2021. The primary outcome is 90-day modified Rankin Score (mRS). The secondary outcomes are angiographic time metrics. Results: Preliminary analysis of one stroke center included 214 EVT patients (n=150 pre-pandemic). Baseline characteristics were comparable between the two periods. Time metrics “last seen normal to puncture” (305.7 vs 407.2 min; p=0.05) and “hospital arrival to puncture” (80.4 vs 121.2 min; p=0.04) were significantly longer during pandemic compared to pre-pandemic. We found no significant difference in 90-day mRS (2.0 vs 2.2; p=0.506) or successful EVT rate (89.6% vs 90%; p=0.93). Conclusions: Our results indicate an increase in key time metrics of EVT in AIS during pandemic, likely related to infection control measures. Despite the delays, we found no difference in clinical outcomes between the two periods.
Between 21 November and 22 December 2020, a SARS-CoV-2 community testing pilot took place in the South Wales Valleys. We conducted a case-control study in adults taking part in the pilot using an anonymous online questionnaire. Social, demographic and behavioural factors were compared in people with a positive lateral flow test (cases) and a sample of negatives (controls). A total of 199 cases and 2621 controls completed a questionnaire (response rates: 27.1 and 37.6% respectively). Following adjustment, cases were more likely to work in the hospitality sector (aOR 3.39, 95% CI 1.43–8.03), social care (aOR 2.63, 1.22–5.67) or healthcare (aOR 2.31, 1.29–4.13), live with someone self-isolating due to contact with a case (aOR 3.07, 2.03–4.62), visit a pub (aOR 2.87, 1.11–7.37) and smoke or vape (aOR 1.54, 1.02–2.32). In this community, and at this point in the epidemic, reducing transmission from a household contact who is self-isolating would have the biggest public health impact (population-attributable fraction: 0.2). As restrictions on social mixing are relaxed, hospitality venues will become of greater public health importance, and those working in this sector should be adequately protected. Smoking or vaping may be an important modifiable risk factor.
Background: Lumbar disc herniation (LDH) is a risk factor for Modic change (MC) development on spinal MRI. MC has been associated with worse pre- and post-operative pain, disability, and health-related quality of life (HRQoL). We examined the relationship between pre-operative MC and post-operative assessment scores for patients receiving discectomy (LD) or transforaminal interbody fusion (TLIF) for LDH. Methods: We reviewed 285 primary single-level surgeries. Pre-operative and 12-month post-operative assessment scores: Visual Analog Scale Leg-Pain (VAS-LP), Oswestry Disability Index (ODI), and Short-Form-36 Physical Component Summary (SF-36-PCS). MC subgroup on pre-operative MRI was recorded by a single neuroradiologist. Results: 179 patients were included. The sample prevalence of MC on pre-operative MRI was 62%; MC2 was most common (35%). No differences in pre-operative scores were identified, regardless of present or absent MC. For the overall cohort, improvement in assessment scores were observed: SF-36 improved an average of 8.2 points (95% CI: [5.8, 10.7]), ODI by 11.3 points (95% CI: [8.7, 14.0]), and VAS by 2.8 points (95% CI: [2.1, 3.5]). In nearly all cases, MCID values were met. Conclusions: Clinically significant improvement in post-operative pain, disability, and HRQoL was observed for both procedures. Modic change on pre-operative MRI was not associated with worse clinical assessment scores.
Background: Vascular closure devices (VCDs) are routinely used in both neurovascular and vascular interventional procedures. The purpose of our study was to assess the safety and efficacy of the VCDs for diagnostic and therapeutic neurovascular and vascular procedures. Methods: The study was approved by the University of Manitoba research ethics board. A retrospective review was conducted of the database between January 2017 and December 2019. The data was collected from the Picture Archiving and Communication System (PACS) and collected in an excel spreadsheet. Patient demographics and clinical information was collected. Descriptive statistics and chi-squared tests were performed using STATA 13 software. A p<0.05 was considered significant. Results: VCD was used in a total of 2072 patients. VCDs were successfully deployed in 94% with 6% failure. Immediate perioperative complications were seen in 6.2% patients. The complication rates were significantly (p=0.025) associated with the type of procedure. Complications were seen significantly (p=0.044) higher in outpatients compared to inpatients and those from emergency room. Conclusions: VCDs were successfully deployed in 96VCDs were successfully deployed in 94% of the patient with 6% perioperative complications. Most of the complications were minor and complications were more commonly associated with outpatients procedures and with diagnostic vascular procedures.
Background: The coronavirus disease 2019 (COVID-19) pandemic has led an implementation of institutional infection control protocols. This study will determine the effects of these protocols on outcomes of acute ischemic stroke (AIS) patients treated with endovascular therapy (EVT). Methods: Uninterrupted time series analysis of the impact of COVID-19 safety protocols on AIS patients undergoing EVT. We analyze data from prospectively collected quality improvement databases at 9 centers from March 11, 2019 to March 10, 2021. The primary outcome is 90-day modified Rankin Score (mRS). The secondary outcomes are angiographic time metrics. Results: Preliminary analysis of one stroke center included 214 EVT patients (n=144 pre-pandemic). Baseline characteristics were comparable between the two periods. Time metrics “last seen normal to puncture” (305.7 vs 407.2 min; p=0.05) and “hospital arrival to puncture” (80.4 vs 121.2 min; p=0.04) were significantly longer during pandemic compared to pre-pandemic. We found no significant difference in 90-day mRS (2.0 vs 2.2; p=0.506) or successful EVT rate (89.6% vs 90%; p=0.93). Conclusions: Our results indicate an increase in key time metrics of EVT in AIS during the pandemic, likely related to infection control measures. Despite the delays, we found no difference in clinical outcomes between the two periods.